arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

MUSTANG BIO, INC.

MBIO
$0.40 ▼ -0.02 (-3.78%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
44 Visible periods
21 Metrics
Peer-ranked Benchmarks
Price Chart
46
Health
Weak
Neutral
auto_awesome

Analytical Summary

MUSTANG BIO, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $2.7M
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -12.3% ↘
FCF / Share $-0.14 ↗
Trailing P/E —
Price / Book 0.4x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

44-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-1.07M
↓ -40.7% —
FCF / Share Free cash flow per share
$-0.14
↑ +4.1% —

Health Breakdown

Returns ↑
28
Cash Quality ↑
91

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 11 years · 44 quarters